0I8F Stock Chart & Stats
$13.26
$0.13(1.00%)
At close: 4:00 PM EDT
$13.26
$0.13(1.00%)
Day’s Range― - ―
52-Week Range$9.45 - $15.25
Previous CloseN/A
Volume5.22K
Average Volume (3M)3.46K
Market Cap
$2.68B
Enterprise Value$4.46K
Total Cash (Recent Filing)$239.00M
Total Debt (Recent Filing)$2.31B
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Oct 29, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend Yield4.73%
Share Statistics
EPS (TTM)-2.74
Shares Outstanding200,326,680
10 Day Avg. Volume4,312
30 Day Avg. Volume3,464
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$13.67Price Target Upside3.07% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)1.42
Revenue Forecast (FY)$3.58B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Installed BaseDentsply Sirona's revenue mix includes high-repeat consumables and an installed base of capital equipment that generates ongoing service, software and parts demand. This creates a durable annuity-like revenue stream that supports cash flow and buffers cyclicality in equipment sales.
Consistent Positive Cash GenerationDespite multi-year earnings weakness, the company consistently generates operating cash and produced meaningful free cash flow TTM. Sustained cash generation provides practical ability to fund restructuring, service debt, and invest in R&D or commercial initiatives over the medium term.
Product Innovation & Distribution ExpansionRecent validated innovations (AI diagnostic aid, dental MRI, new endodontic systems) plus expanded distributor deals indicate strengthening product pipeline and go-to-market reach. These structural moves can expand addressable markets and accelerate durable adoption over 2–3 years.
Bears Say
Multi‑year Revenue Declines & LossesTop-line erosion across several years combined with persistent net losses undermines profitability resilience. Continued declines constrain reinvestment capacity, limit scale benefits, and make achieving consistent, sustainable profit recovery more challenging over the medium term.
Elevated LeverageMaterial leverage and a net debt/EBITDA around mid-single digits reduce financial flexibility and raise refinancing risk if earnings remain weak. Debt obligations limit capacity for large-scale investments or M&A and increase sensitivity to slower cash-flow recovery or higher rates.
Structural Margin PressureSignificant margin compression from tariffs, unfavorable mix and lower volumes, plus ongoing distributor destocking and a pending ~$30M sell-through headwind, threaten sustainable margin recovery. These structural cost and channel pressures could persist into multiple quarters.
DENTSPLY SIRONA News
0I8F FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest share price was $9.45 and its highest was $15.25 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $2.68B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Oct 29, 2026 which is in 83 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Aug 06, 2026. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.348 by $0.172.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 4.73%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.34.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 200,326,680 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $0.52 in its last earnings report, beating expectations of $0.348. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in GB:0I8F
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.67 (3.07% Upside)
$13.67 (3.07% Upside)
Blogger Sentiment
Neutral
GB:0I8F Sentiment 67%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth $515.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.26%
12-Months-Change
Fundamentals
Return on Equity
4.73%
Trailing 12-Months
Asset Growth
-13.57%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
0I8F Company Deck
0I8F Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of encouraging operational and financial actions alongside notable near-term challenges. Positives include improved operating cash flow, active deleveraging (≈$79–$80M debt retired), early cost savings (≈$20M OpEx reduction in Q1) and meaningful innovation launches (AI diagnostic aid with ~46% sensitivity improvement, dental MRI clearance, new endodontic tools). Management also maintained full-year guidance and highlighted distributor expansion and early commercial traction. Offsetting these are material constant-currency revenue declines (Q1 cc sales down 6.7%, down 4.5% excluding one-time items), significant margin compression (adjusted EBITDA down 430 bps; gross profit down 560 bps), softness in several key segments (OIS, EDS, IPS, CTS), tariff-related margin pressure, distributor destocking, and an expected ~$30M inventory sell-through headwind later in the year. Given the roughly balanced set of meaningful positives (cash, cost saves, innovation, distribution) and negatives (sales declines, margin pressure, macro/timing risks), the overall tone is cautiously constructive but realistic about near-term headwinds.View all GB:0I8F earnings summaries0I8F Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
0I8F Stock 12 Month Forecast
Average Price Target
$13.67
▲(3.07% Upside)